Pomegranate Endurance Performance Randomized Trial: What the Evidence Says

Quick Answer

Pomegranate Endurance Performance Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 narrative review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• -Which populations and contexts (training status, sex and age, dietary pattern and energy availability, heat or hypoxia, and congested competition schedules) shift the balance from benefit to risk? [Mănescu Dan Cristian (2026); evidence level 3]
• This review addresses that problem for athletes and practitioners seeking evidence-based guidance. [Mănescu Dan Cristian (2026); evidence level 3]
• EIMD is characterized by microscopic myofibrillar disruptions followed by a secondary inflammatory response as leukocytes infiltrate damaged tissue, with clinical and functional sequelae, including DOMS, swelling, reduced muscle function, and leakage of muscle enzymes such as creatine kinase into the bloodstream. [Rezaei Gholamreza (2026); evidence level 4]
• While EIMD-related inflammation is part of the normal exercise response, excessive damage can temporarily impair performance capacity; experimental studies have shown that DOMS and the associated loss of strength typically persist for several days and, in more severe cases, can remain evident for a week or longer, during which athletes may struggle to maintain usual training intensity or competitive performance. [Rezaei Gholamreza (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

For pomegranate endurance performance randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Mănescu Dan Cristian (2026). Antioxidants and Exercise: A Redox-Informed Framework for Training Adaptation, Performance, and Recovery. DOI: 10.3390/antiox15040456. PMCID: PMC13113188. PMID: 42072098. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13113188/
• Rezaei Gholamreza (2026). Individual responses to pomegranate juice on recovery from exercise-induced muscle damage in collegiate male volleyball players. DOI: 10.1080/15502783.2026.2642149. PMCID: PMC13104005. PMID: 42015544. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13104005/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.